4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-011643
EVP, Chief Dev. Officer sold 2,929 shares at $12.12 ($35,509)
From the SEC's structured data for this filing
Trades in this filing
Frenkel Ran · EVP, Chief Dev. Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-17 | Sale : show line 1 in the form | −2,929 | $12.12 | $35,509 | 101,703 | D |
| Open-market sales · 2,929 sh · avg $12.12 · $35,509 | ||||||
Loading xslF345X03/doc4.xml…